Recombinant Mouse LRIG3 Protein，His

LRIG3 is a member of the LRIG (leucine-rich repeats and immunoglobulin-like domains) family of proteins, which are known to play significant roles in regulating cell signaling pathways, particularly those involved in growth factor receptor activity. Specifically, LRIG proteins interact with receptor tyrosine kinases (RTKs) and are implicated in modulating cellular responses to various stimuli, influencing processes such as cell proliferation, differentiation, and survival. The study of LRIG3, which is primarily expressed in the nervous system and certain tissues, has garnered attention due to its potential involvement in cancer biology and neurodevelopmental disorders. Several studies have suggested that LRIG3 may act as a tumor suppressor by inhibiting excessive RTK signaling, thereby contributing to the regulation of cellular homeostasis. Additionally, alterations in LRIG3 expression have been associated with various malignancies, making it a potential biomarker for cancer diagnosis and prognosis. Given the growing interest in targeted therapies that exploit these molecular pathways, understanding the structure and function of LRIG3 through recombinant protein expression becomes critical. Research focusing on the recombinant expression of LRIG3 allows for a more detailed investigation of its functional roles and interactions within the cellular context, potentially revealing novel therapeutic targets or strategies for diseases related to dysregulated signaling pathways.